As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...

While LSD and psilocybin typically distort or enhance a person’s experience of their current environment, DMT seems to shake ...

Design Therapeutics has its proprietary GeneTAC platform. This gives them a small-molecule way to target repeat-expansion ...

The WHO has issued its first comprehensive guidelines for managing Ebola and Marburg diseases, stressing early supportive ...

A local doctor is building a medical facility he hopes will relieve a life-threatening bed shortage at King Edward VII ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World Health Organization (WHO) has released its first comprehensive guidelines for ...

Manikomycin is being hailed as a potential breakthrough in the fight against antibiotic-resistant bacteria. Perhaps it is.

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

Feeling abandoned and overwhelmed, families are turning to controversial new therapies backed by the US health secretary ...

TPU researchers and their colleagues have successfully synthesized superparamagnetic nanoparticles of gallium-doped magnetite ...

There are currently no approved drugs that target Bundibugyo - the species of Ebola responsible for this outbreak.